Shandong Pharmaceutical Glass Co Ltd (600529) — Tangible Net Worth Ratio

Latest as of March 2026: 97.1%

Shandong Pharmaceutical Glass Co Ltd (600529) has a Tangible Net Worth Ratio of 97.1% as of March 2026. This metric is calculated by deducting intangible assets (CN¥240.30 Million) from net assets (CN¥8.38 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See Shandong Pharmaceutical Glass Co Ltd short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.

Tangible NW Ratio

97.1%
Tangible equity / total equity

Net Assets (Equity)

CN¥8.38 Billion
CNY

Intangible Assets

CN¥240.30 Million
Goodwill, patents, brand value

Total Assets

CN¥10.14 Billion
CNY

Shandong Pharmaceutical Glass Co Ltd Tangible Net Worth Ratio (1999–2025)

This chart shows how Shandong Pharmaceutical Glass Co Ltd's Tangible Net Worth Ratio has changed across 27 annual periods from 1999 to 2025. As of March 2026, the ratio stands at 97.1%, reflecting net assets of CN¥8.38 Billion with intangible assets of CN¥240.30 Million CNY. See Shandong Pharmaceutical Glass Co Ltd (600529) defensive interval to measure how many days the company can operate on defensive assets alone.

Annual Tangible Net Worth Ratio for Shandong Pharmaceutical Glass Co Ltd (1999–2025)

The table below presents the year-by-year Tangible Net Worth Ratio for Shandong Pharmaceutical Glass Co Ltd from 1999 to 2025, covering 27 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see Shandong Pharmaceutical Glass Co Ltd (600529) market capitalisation.

Year Tangible NW Ratio Net Assets (CNY) Intangible Assets Total Assets Change (pp)
2025 97.1% CN¥8.29 Billion CN¥241.97 Million CN¥10.04 Billion ▲ +0.2 pp
2024 96.9% CN¥8.01 Billion CN¥247.24 Million CN¥10.14 Billion ▲ +0.3 pp
2023 96.6% CN¥7.53 Billion CN¥253.67 Million CN¥9.32 Billion ▲ +0.4 pp
2022 96.3% CN¥6.96 Billion CN¥260.37 Million CN¥8.78 Billion ▲ +0.5 pp
2021 95.8% CN¥4.67 Billion CN¥198.37 Million CN¥6.41 Billion ▲ +0.5 pp
2020 95.2% CN¥4.26 Billion CN¥203.25 Million CN¥5.62 Billion ▼ -0.3 pp
2019 95.6% CN¥3.87 Billion CN¥171.81 Million CN¥5.17 Billion ▼ -0.1 pp
2018 95.7% CN¥3.53 Billion CN¥153.04 Million CN¥4.62 Billion ▼ -0.9 pp
2017 96.5% CN¥3.25 Billion CN¥112.52 Million CN¥4.18 Billion ▼ -0.2 pp
2016 96.8% CN¥3.04 Billion CN¥98.69 Million CN¥3.90 Billion ▲ +0.7 pp
2015 96.0% CN¥2.24 Billion CN¥89.04 Million CN¥2.97 Billion ▼ -0.1 pp
2014 96.1% CN¥2.13 Billion CN¥81.96 Million CN¥2.82 Billion ▲ +0.1 pp
2013 96.1% CN¥2.03 Billion CN¥79.72 Million CN¥2.71 Billion ▲ +0.3 pp
2012 95.8% CN¥1.94 Billion CN¥82.06 Million CN¥2.61 Billion ▲ +0.3 pp
2011 95.5% CN¥1.85 Billion CN¥82.97 Million CN¥2.49 Billion ▼ -2.2 pp
2010 97.7% CN¥1.75 Billion CN¥39.90 Million CN¥2.52 Billion ▲ +0.3 pp
2009 97.4% CN¥1.59 Billion CN¥40.83 Million CN¥2.22 Billion ▲ +0.4 pp
2008 97.1% CN¥1.45 Billion CN¥42.36 Million CN¥1.99 Billion ▲ +0.4 pp
2007 96.7% CN¥1.31 Billion CN¥43.52 Million CN¥1.87 Billion ▼ -2.3 pp
2006 99.0% CN¥924.74 Million CN¥9.14 Million CN¥1.63 Billion ▲ +0.2 pp
2005 98.9% CN¥861.57 Million CN¥9.89 Million CN¥1.43 Billion ▲ +0.1 pp
2004 98.7% CN¥797.19 Million CN¥10.17 Million CN¥1.23 Billion ▲ +0.2 pp
2003 98.5% CN¥725.23 Million CN¥10.72 Million CN¥1.04 Billion ▼ -0.4 pp
2002 99.0% CN¥650.32 Million CN¥6.80 Million CN¥943.59 Million ▲ +2.1 pp
2001 96.9% CN¥224.34 Million CN¥7.05 Million CN¥467.24 Million ▲ +0.8 pp
2000 96.0% CN¥188.33 Million CN¥7.49 Million CN¥394.61 Million ▲ +0.4 pp
1999 95.6% CN¥158.78 Million CN¥6.94 Million CN¥353.45 Million
pp = percentage points